Infectious Disorders - Drug Targets
Title:Editorial [Hot Topic: B Lymphocytes as Programmers and Effectors of Immunity, their Roles Beyond Antibody Production (Guest Editor: Simon Fillatreau)]
Volume: 12 Issue: 3
Author(s): Simon Fillatreau
Affiliation:
Export Options
About this article
Cite this article as:
Fillatreau Simon, Editorial [Hot Topic: B Lymphocytes as Programmers and Effectors of Immunity, their Roles Beyond Antibody Production (Guest Editor: Simon Fillatreau)], Infectious Disorders - Drug Targets 2012; 12 (3) . https://dx.doi.org/10.2174/187152612800564428
DOI https://dx.doi.org/10.2174/187152612800564428 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systematic and Pairwise Analysis of the Effects of Aromatic Halogenation and Trifluoromethyl Substitution on Human Liver Microsomal Clearance
Drug Metabolism Letters Multi-Target Mining of Alzheimer Disease Proteome with Hansch’s QSBR-Perturbation Theory and Experimental-Theoretic Study of New Thiophene Isosters of Rasagiline
Current Drug Targets Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Inflammation, Sleep, Obesity and Cardiovascular Disease.
Current Vascular Pharmacology Editorial: Novel Perspectives in the Treatment of Epilepsy
Current Pharmaceutical Design Dehydroepiandrosterone, Dehydroepiandrosterone Sulfate and Related Steroids: Their Role in Inflammatory, Allergic and Immunological Disorders
Current Drug Targets - Inflammation & Allergy GABA Puts a Stop to Pain
Current Drug Targets - CNS & Neurological Disorders Pathophysiology of Sepsis and Recent Patents on the Diagnosis, Treatment and Prophylaxis for Sepsis
Recent Patents on Inflammation & Allergy Drug Discovery The Role of Antihistamines in the Management of Allergic Rhinitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Adrenocortical Crisis Triggered by Levothyroxine in an Unrecognized Autoimmune Polyglandular Syndrome Type-2: A Case Report with Review of the Literature
Current Drug Safety MicroRNA Dysregulation in Alzheimer's Disease
CNS & Neurological Disorders - Drug Targets The Assessment of Some Metabolic Markers by Combination of Ursolic Acid Supplementation and Resistance Training in Young Older Obese Women
Endocrine, Metabolic & Immune Disorders - Drug Targets Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Current Protein & Peptide Science Heterocyclization of 2-(2-phenylhydrazono)cyclohexane-1,3-dione to Synthesis Thiophene, Pyrazole and 1,2,4-triazine Derivatives with Anti-Tumor and Tyrosine Kinase Inhibitions
Anti-Cancer Agents in Medicinal Chemistry Is Targeting microRNAs the Philosopher’s Stone for Vascular Disease?
Current Vascular Pharmacology Methotrexate in the Treatment of Psoriasis and Rheumatoid Arthritis: Mechanistic Insights, Current Issues and Novel Delivery Approaches
Current Pharmaceutical Design Role of Lycopene in the Control of ROS-Mediated Cell Growth: Implications in Cancer Prevention
Current Medicinal Chemistry Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity Against Staphylococcus aureus Skin Infection
Current Medicinal Chemistry HIV Management: New Approaches
Current Drug Therapy Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR
Current Neurovascular Research